Inconclusiveness of psychometric testing of medication adherence questionnaires
Uloženo v:
| Název: | Inconclusiveness of psychometric testing of medication adherence questionnaires |
|---|---|
| Autoři: | Isabelle Arnet, Christiane Eickhoff, Laura J Sahm, Sabine Caloz, Michael Mittag, Martin Schulz, Samuel S Allemann |
| Zdroj: | Eur J Clin Pharmacol European journal of clinical pharmacology Germany |
| Informace o vydavateli: | Springer Science and Business Media LLC, 2024. |
| Rok vydání: | 2024 |
| Témata: | Assessment of Medication Adherence, Questionnaires, Psychometrics, Research, Reproducibility of Results, Medication Adherence/statistics, Validity, Self-report, Surveys and Questionnaires/standards [MeSH], Reproducibility of Results [MeSH], Humans [MeSH], Medication adherence, Psychometric testing, Psychometrics [MeSH], Reliability, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Surveys and Questionnaires, Humans, MEDICATION ADHERENCE, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik, 0305 other medical science |
| Popis: | Purpose To propose a paradigm change for the validation procedures of medication adherence questionnaires. Methods A total of 121 validation procedures of unique questionnaires for medication adherence were analyzed. Results “Construct validity” and “internal consistency” were most often assessed, and test results varied largely. A more in-depth analysis indicated that the assessment of medication non-adherence included distinct but related constructs, such as the extent to which doses are missed, and the attempt to identify different facets of medication-taking behavior. Consequently, each construct requires a different measurement approach with different psychometric tests for establishing its validity and reliability. Conclusion Results show that assessing the validity and reliability of adherence questionnaires with standard procedures including statistical tests is inconclusive. Refinement of the constructs of non-adherence is needed in pharmacy and medical practice. We suggest a distinction between the (i) extent of missed doses over the past 2 weeks, (ii) modifiable reasons for non-adherence behavior, and (iii) unmodifiable factors of non-adherence. Validation procedures and corresponding statistical methods should be selected according to the specific single constructs. |
| Druh dokumentu: | Article Other literature type |
| Popis souboru: | application/pdf |
| Jazyk: | English |
| ISSN: | 1432-1041 0031-6970 |
| DOI: | 10.1007/s00228-024-03684-8 |
| DOI: | 10.17169/refubium-43294 |
| Přístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/38647703 http://hdl.handle.net/10147/645970 https://repository.publisso.de/resource/frl:6523127 https://refubium.fu-berlin.de/handle/fub188/43578 https://doi.org/10.1007/s00228-024-03684-8 https://doi.org/10.17169/refubium-43294 |
| Rights: | CC BY |
| Přístupové číslo: | edsair.doi.dedup.....9c764347eef4980f18364f5f8d32e409 |
| Databáze: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | Purpose To propose a paradigm change for the validation procedures of medication adherence questionnaires. Methods A total of 121 validation procedures of unique questionnaires for medication adherence were analyzed. Results “Construct validity” and “internal consistency” were most often assessed, and test results varied largely. A more in-depth analysis indicated that the assessment of medication non-adherence included distinct but related constructs, such as the extent to which doses are missed, and the attempt to identify different facets of medication-taking behavior. Consequently, each construct requires a different measurement approach with different psychometric tests for establishing its validity and reliability. Conclusion Results show that assessing the validity and reliability of adherence questionnaires with standard procedures including statistical tests is inconclusive. Refinement of the constructs of non-adherence is needed in pharmacy and medical practice. We suggest a distinction between the (i) extent of missed doses over the past 2 weeks, (ii) modifiable reasons for non-adherence behavior, and (iii) unmodifiable factors of non-adherence. Validation procedures and corresponding statistical methods should be selected according to the specific single constructs. |
|---|---|
| ISSN: | 14321041 00316970 |
| DOI: | 10.1007/s00228-024-03684-8 |